BiomX Inc. (PHGE)

BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $15.70 million. The enterprise value is $8.43 million.

Market Cap	15.70M
Enterprise Value	8.43M

Important Dates

The next estimated earnings date is Monday, May 19, 2025, after market close.

Earnings Date	May 19, 2025
Ex-Dividend Date	n/a

Share Statistics

BiomX has 24.97 million shares outstanding. The number of shares has increased by 155.95% in one year.

Current Share Class	24.97M
Shares Outstanding	24.97M
Shares Change (YoY)	+155.95%
Shares Change (QoQ)	+11.33%
Owned by Insiders (%)	2.70%
Owned by Institutions (%)	32.53%
Float	17.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.08
P/TBV Ratio	2.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.40.

Current Ratio	2.48
Quick Ratio	2.19
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-40.72

Financial Efficiency

Return on equity (ROE) is -130.21% and return on invested capital (ROIC) is -85.62%.

Return on Equity (ROE)	-130.21%
Return on Assets (ROA)	-65.10%
Return on Invested Capital (ROIC)	-85.62%
Return on Capital Employed (ROCE)	-101.67%
Revenue Per Employee	n/a
Profits Per Employee	-$311,000
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BiomX has paid $13,000 in taxes.

Income Tax	13,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.64% in the last 52 weeks. The beta is 1.32, so BiomX's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	-84.64%
50-Day Moving Average	0.72
200-Day Moving Average	1.24
Relative Strength Index (RSI)	49.86
Average Volume (20 Days)	184,206

Short Selling Information

The latest short interest is 31,624, so 0.13% of the outstanding shares have been sold short.

Short Interest	31,624
Short Previous Month	9,818
Short % of Shares Out	0.13%
Short % of Float	0.18%
Short Ratio (days to cover)	0.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-35.55M
Pretax Income	-37.11M
Net Income	-17.73M
EBITDA	-33.75M
EBIT	-35.55M
Earnings Per Share (EPS)	-$3.36

Balance Sheet

The company has $16.86 million in cash and $9.58 million in debt, giving a net cash position of $7.27 million or $0.29 per share.

Cash & Cash Equivalents	16.86M
Total Debt	9.58M
Net Cash	7.27M
Net Cash Per Share	$0.29
Equity (Book Value)	24.15M
Book Value Per Share	0.30
Working Capital	12.25M

Cash Flow

In the last 12 months, operating cash flow was -$36.98 million and capital expenditures -$30,000, giving a free cash flow of -$37.01 million.

Operating Cash Flow	-36.98M
Capital Expenditures	-30,000
Free Cash Flow	-37.01M
FCF Per Share	-$1.48

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-155.95%
Shareholder Yield	-155.95%
Earnings Yield	-112.88%
FCF Yield	-235.67%

Analyst Forecast

The average price target for BiomX is $23.00, which is 3,556.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.00
Price Target Difference	3,556.60%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	0.50%

Stock Splits

The last stock split was on August 26, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Aug 26, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1